Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
BlueRock Therapeutics, FUJIFILM Cellular Dynamics, and Opsis Therapeutics Enter Strategic R&D Alliance
BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, FUJIFILM […]
New Measures to Boost Response to B1.617.2 Variant
The B1.617.2 variant of concern is beginning to spread increasingly rapidly in certain areas across […]
Johnson & Johnson Joins World Health Organization in Efforts to Prevent Spread of Ebola in West Africa
Johnson & Johnson (NYSE: JNJ) (the Company) today announced the World Health Organization (WHO) and […]
New Research to Study Benefits of Personalised Pacemaker Programming
Researchers BHF have funded at the University of Leeds will investigate how people living with […]
Moderna Announces New Supply Agreement with Australia for 25 Million Doses of its COVID-19 Vaccine
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
Pink Luminous Breast (PLB) Takes Steps Toward FDA Class III Approval
Pink Luminous Breast (PLB) is continuing to make strides in breast cancer awareness with a new […]
VXPASS Selected to Manage and Verify Digital Records for COVID-19 Vaccination Rollout for Kingdom of Lesotho
VXPASS, a blockchain-based platform built to manage, store and verify records for global COVID-19 vaccination […]
Amgen Tezepelumab BLA Submitted to U.S. FDA
Amgen (NASDAQ:AMGN) today announced its partner AstraZeneca (NASDAQ:AZN) submitted a Biologics License Application (BLA) to […]
3D Heart Scans to Give Faster Treatment
People in England with coronary heart disease will be seen, diagnosed and treated up to […]
FagronLab™ UV Air Steriliser Proves Successful Against COVID-19 Virus
A leading pharmaceutical company has launched a new UV air steriliser which has been tested […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more